Current use of imatinib in the treatment of chronic myeloid leukemia

被引：0
|
作者：
O'Dwyer, M [1 ]
机构：
[1] Univ Coll Hosp Galway, Dept Hematol, Galway, Ireland
来源：
HAEMATOLOGICA | 2003年 / 88卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：241 / 244
页数：4
相关论文
共 50 条
  • [41] Treatment modalities in hematology: Imatinib mesylate as therapy for chronic myeloid leukemia
    A. Gratwohl
    International Journal of Hematology, 2002, 76 : 149 - 149
  • [42] Treatment modalities in hematology: Imatinib mesylate as therapy for chronic myeloid leukemia
    Gratwohl, A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 1) : 149 - 149
  • [43] INFLUENCE OF LATE TREATMENT ON HOW CHRONIC MYELOID LEUKEMIA RESPONDS TO IMATINIB
    Costa Scerni, Ana Carolina
    Alvares, Leonardo Azevedo
    Beltrao, Ana Cristina
    Bentes, Ie Regina
    Azevedo, Tereza Cristina
    Bentes, Alessandra Quinto
    Rodrigues Lemos, Jose Alexandre
    CLINICS, 2009, 64 (08) : 731 - 734
  • [44] Molecularly targeted treatment of chronic myeloid leukemia: beyond the imatinib era
    Mughal, TI
    Goldman, JM
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 209 - 220
  • [45] Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia
    Peggs, K
    Mackinnon, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11): : 1048 - 1050
  • [46] Effect of Imatinib treatment on renal anaemia in chronic myeloid leukemia patients
    Singh, Avinash Kumar
    Vidyadhari, Arya
    Bhurani, Dinesh
    Agrawal, Narendra
    Ahmed, Rayaz
    Sharma, Manju
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (08) : 1928 - 1934
  • [47] Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment
    Angriman, Federico
    Gutierrez Acevedo, Maria Nelly
    Sol Rossi, Maria
    Gimenez Conca, Alberto Daniel
    Otero, Victoria
    Alberto Arbelbide, Jorge
    Michelangelo, Hernan
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (02) : 193 - 194
  • [48] Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate
    Zonder J.A.
    Schiffer C.A.
    Current Hematologic Malignancy Reports, 2006, 1 (3) : 141 - 151
  • [49] A CHRONIC MYELOID LEUKEMIA CASE WHO HAS DISCONTINUED IMATINIB TREATMENT
    Malkan, Umit Yavuz
    Gunes, Gursel
    Aslan, Tuncay
    Yayar, Okan
    Ozcebe, Osman Ilhami
    Haznedaroglu, Ibrahim Celallettin
    LEUKEMIA RESEARCH, 2015, 39 : SS27 - SS28
  • [50] THE IMPACT OF AGE ON THE EFICACY AND TOXICITY OF IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA
    Santos-Sousa, P.
    Guerra, L.
    Gomez, B.
    Valle, S.
    Lopes, C.
    Raposo, J.
    Martins, C.
    Costa, M. J.
    Esteves, G.
    Fajardo, J.
    Lacerda, J. Forjaz
    do Carmo, J. Alves
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 540 - 540
12345